Mitochon Pharmaceuticals Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 3

Mitochon Pharmaceuticals General Information

Description

Developer of drugs designed to target the mitochondria for a host of serious diseases with significant unmet medical needs. The company's drugs are primarily focused on neurodegenerative and neuromuscular diseases, enabling healthcare providers to treat huntington's disease, multiple sclerosis oroptic neuritis, wolfram syndrome, epilepsy, traumatic brain injury, duchenne muscular dystrophy azheimer's disease and parkinson disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 970 Cross Lane
  • Blue Bell, PA 19422
  • United States
+1 (215) 000-0000

Mitochon Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitochon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 30-Nov-2019 $1.5M 00.000 Completed Clinical Trials - Phase 1
4. Angel (individual) 21-Dec-2017 00000 00.000 Completed Generating Revenue
3. Grant 03-Oct-2017 000 00.000 Completed Generating Revenue
2. Early Stage VC 17-May-2016 $1.6M $2.35M Completed Generating Revenue
1. Early Stage VC 31-Mar-2015 $750K $750K Completed Generating Revenue
To view Mitochon Pharmaceuticals’s complete valuation and funding history, request access »

Mitochon Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs designed to target the mitochondria for a host of serious diseases with significant unmet medical nee
Drug Discovery
Blue Bell, PA
5 As of 2017
00.000
0000000000 0 00.000

00000000

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000 000000000
Ness Ziona, Israel
0000
00.00 0000-00-00
00000000000 0000

0000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mitochon Pharmaceuticals Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mitoconix Bio Venture Capital-Backed Ness Ziona, Israel 0000 00000000000 0000
0000000 000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
0000000000 Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
You’re viewing 3 of 3 competitors. Get the full list »

Mitochon Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Robert Alonso Co-Founder, President & Chief Executive Officer
Christopher Yankana Chief Financial Officer
John Geisler Ph.D Co-Founder & Chief Scientific Officer
Marcus Keep MD Acting Chief Medical Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Mitochon Pharmaceuticals Board Members (1)

Name Representing Role Since
Anthony Jannetta Mitochon Pharmaceuticals Board Member 000 0000
To view Mitochon Pharmaceuticals’s complete board members history, request access »

Mitochon Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mitochon Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
YT Angels Other Minority 000 0000 000000 0
To view Mitochon Pharmaceuticals’s complete investors history, request access »